Neuraminidase in cultured fibroblasts and leucocytes of homozygotes and heterozygotes for the mucolipidosis II gene (I-cell disease)

American Journal of Medical Genetics
M PotierM Bélisle

Abstract

The significance of neuraminidase deficiency reported to be the primary defect in mucolipidosis II has been evaluated by determination of this enzyme activity in cultured fibroblasts, culture medium, and leucocytes from homozygote and heterozygous carriers of the disease. A new and sensitive fluorometric assay of neuraminidase was used with sodium (4-methylumbeliferyl-alpha-D-N-acetylneuraminate) as substrate. We report: 1) nearly total deficiency of neuraminidase in mucolipidosis fibroblasts, 2) partial deficiency of this enzyme in leucocytes of one patient, 3) this decreased activity ceases to exist following Triton X-100 treatment, and 4) intermediary mean neuraminidase activity in fibroblasts and leucocytes from obligate heterozygotes. Although these results would be consistent with the suggestion that neuraminidase deficiency is the primary defect in this disease, evidence from the work of other authors suggests that the enzyme deficiency results from a secondary effect of the mucolipidosis II mutation.

References

Jul 12, 1976·Biochemical and Biophysical Research Communications·G H ThomasJ W Bace
May 30, 1978·Biochemical and Biophysical Research Communications·D A WengerC Wharton
May 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·A KaplanW S Sly
Dec 21, 1977·Biochemical and Biophysical Research Communications·J S O'Brien
Jan 1, 1977·American Journal of Medical Genetics·T E Kelly, G Graetz
Jan 1, 1978·FEBS Letters·G Strecker, J C Michalski
Feb 13, 1978·Biochimica Et Biophysica Acta·G D Vladutiu, M C Rattazzi
Jan 1, 1976·Annual Review of Biochemistry·R Kornfeld, S Kornfeld
Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·W S SlyS Schlesinger
Jan 24, 1977·Biochemical and Biophysical Research Communications·M CantzJ Spranger
May 10, 1977·Human Genetics·J Vidgoff, N R Buist
Dec 1, 1975·Biochemical and Biophysical Research Communications·G D Vladutiu, M C Rattazzi
Sep 1, 1971·The Journal of Pediatrics·J G LeroyA C Crocker
Nov 15, 1972·Biochemical and Biophysical Research Communications·S Hickman, E F Neufeld
Mar 15, 1974·Biochemical and Biophysical Research Communications·S HickmanE F Neufeld
Mar 1, 1973·Archives of Biochemistry and Biophysics·P BöhlenS Udenfriend

❮ Previous
Next ❯

Citations

Aug 18, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·Y Ben-YosephH L Nadler
Jan 1, 1981·The International Journal of Biochemistry·J A Alhadeff, S Wolfe
Apr 1, 1984·Hoppe-Seyler's Zeitschrift für physiologische Chemie·R SchauerH Tschesche
Feb 1, 1984·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·W R Den Tandt, R Brossmer
Jan 1, 1987·Immunogenetics·M AyaneJ Klein
Jun 1, 1984·Biochemical Medicine·W R den Tandt, S Scharpe
Jan 1, 1987·Journal of Community Health Nursing·S K Ostwald, H Y Williams
Jan 1, 1984·Pediatric Radiology·O O AdetoroA Anjorin
Jun 1, 1982·Clinical Genetics·Y Ben-YosephH L Nadler
Dec 4, 1980·Biochimica Et Biophysica Acta·V N HongP Durand
Sep 30, 1982·Biochemical and Biophysical Research Communications·F VerheijenH Galjaard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.